ScholarIQanswers from OpenAlex & ORCID
Li Yu
ResearcherPublications, citations & collaboration network
Li Yu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Li Yu have?
ScholarIQindexed works
Li Yu has 706 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Li Yu have?
ScholarIQcitation count
Li Yu has 13,921 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Li Yu?
ScholarIQh-index
Li Yu has an h-index of 57 in OpenAlex.
What is the i10-index of Li Yu?
ScholarIQi10-index
Li Yu has an i10-index of 261 in OpenAlex.
What is the ORCID of Li Yu?
ScholarIQorcid
The ORCID for Li Yu is on the source record.
What is the OpenAlex record for Li Yu?
ScholarIQopenalex
The OpenAlex for Li Yu is on the source record.
What are the most-cited papers on Li Yu?
ScholarIQmost cited works
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
J Costello, Michael C. Frühwald, Dominic J. Smiraglia, Laura J. Rush, Gavin P. Robertson, Xīn Gào, Fred A. Wright, Jamison D. Feramisco, Païvi Peltomäki, James C. Lang, David E. Schuller, Li Yu, Clara D. Bloomfield, Michael A. Caligiuri, Allan J. Yates, Ryo Nishikawa, H.-J. Su Huang, Nicholas J. Petrelli, Xueli Zhang, M. Sue O’Dorisio, William A. Held, Webster K. Cavenee, Christoph Plass
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Erik Kupperman, Edmund C. Lee, Yueying Cao, Bret Bannerman, Michael Fitzgerald, Allison Berger, Jie Yu, Yang Yu, Paul Hales, Frank J. Bruzzese, Jane Liu, Jonathan L. Blank, Khristofer Garcia, Christopher Tsu, Larry Dick, Paul Fleming, Li Yu, Mark Manfredi, Mark Rolfe, Joe Bolen
SIRT3 Deacetylates Mitochondrial 3-Hydroxy-3-Methylglutaryl CoA Synthase 2 and Regulates Ketone Body Production
Tadahiro Shimazu, Matthew D. Hirschey, Lan Hua, Kristin E. Dittenhafer‐Reed, Bjoern Schwer, David B. Lombard, Li Yu, Jakob Bunkenborg, Frederick W. Alt, John M. Denu, Matthew P. Jacobson, Eric Verdin
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Yue Shi, Mei Dong, Xiaoting Hong, Wen Zhang, J. Feng, Jing-Zhong Zhu, Li Yu, Xiao Ke, He Huang, Z. Shen, Yun Fan, W. Li, Xiaohong Zhao, Jianyong Qi, He Huang, Daobin Zhou, Zhengwen Ning, Xianping Lu
Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation
Sergei Kusmartsev, Li Yu, Shu‐Hsia Chen